This announcement is a separate document:
湖北瑞通天元律师事务所关于嘉必优生物技术（武汉）股份有限公司2022 年限制性股票激励计划首次授予部分第一个归属期归属条件成就和部分限制性股票作废事项之法律意见书
Legal opinion of Hubei Ruitong Tianyuan Law Firm on matters where the 2022 restricted stock incentive plan of Jiabiyou Biotechnology (Wuhan) Co., Ltd. granted for the first time the fulfillment of vesting conditions during the first vesting period and the
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.